ELYSIAN® Clínica Médica & Neurologia
Aug 3, 2020
"Cerebrospinal Fluid Based Biomarker Evidence of Amyloidosis in Dementia with Lewy Bodies Depends upon APOE-ε4 Carrier Status", aula apresentada na sessão inaugural da Professional Interest Area de Lewy Body Dementias da AAIC>20 - Alzheimer's Association International Conference.